DHR · Earnings call · 2026Q3T · Full report

Life Sciences Demand Trends

DANAHER CORP /DE/ · 2026-10-21 · Importance 26 · Surprise 32

Pall’s applied filtration business grew at a mid-single-digit rate, driven by continued robust demand in aerospace and microelectronics. Life Sciences instruments also grew mid-single digits, with SCIEX seeing strong pharma and biopharma demand, a modest improvement in U.S. academic spending, and momentum for the ZenoTOF 8600. Beckman Coulter Life Sciences reported strong results and increased demand for AI-enabled automation solutions and services. Life Sciences consumables grew low single digits, supported by IDT’s MRD and next-generation sequencing lines and improved academic demand and pharma/biopharma commercial traction at Abcam.

Key facts

• Danaher’s Life Sciences business beat internal expectations for the third consecutive quarter.
• Danaher saw continued strength in clinical and applied markets, including microelectronics at Pall.